Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,809 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Building common understanding: seeking consensus and defining social prescribing across contexts - a collective commentary on a Delphi study.
Muhl C, Mulligan K, Giurca BC, Polley MJ, Bloch G, Nowak DA, Osborn-Forde C, Hsiung S, Lee KH, Herrmann WJ, Baker JR, Stokes-Lampard DHJ, Everington SS, Dixon M, Wachsmuth I, Figueiredo C, Skjerning HT, Rojatz D, Chen YD, Heijnders ML, Wallace C, Howarth M, Watanabe D, Bertotti M, Jansson AH, Althini S, Holzinger F, Dooler DG, Brand S, Anfilogoff TJ, Fancourt D, Nelson MLA, Tierney S, Leitch A, Nam HK, Card KG, Hayes D, Slade S, Essam MA, Palmer GA, Welch VA, Robinson D, Hilsgen L, Taylor N, Nielsen RØ, Vidovic D, McDaid EM, Hoffmeister LV, Bonehill J, Siegel A, Bártová A, Acurio-Páez D, Mendive JM, Husk K. Muhl C, et al. Among authors: dixon m. BMC Health Serv Res. 2024 Oct 24;24(1):1280. doi: 10.1186/s12913-024-11603-x. BMC Health Serv Res. 2024. PMID: 39449029 Free PMC article.
Politicians, experts, and patient representatives call for the UK government to reverse the rate of antidepressant prescribing.
Davies J, Read J, Kruger D, Crisp N, Lamb N, Dixon M, Everington S, Hollins S, Moncrieff J, Giurca BC, van Tulleken C, Chouinard G, Dooley M, Guy A, Horowitz M, Kinderman P, Johnstone L, Montagu L, Nardi AE, Stacey S, Bell M, Tresidder A, Watson J, Lewis S, Spada M, Payne R, Akhtar N, Buckland C, Levett J, Whitcombe S, Marshall-Andrews L. Davies J, et al. Among authors: dixon m. BMJ. 2023 Dec 5;383:2730. doi: 10.1136/bmj.p2730. BMJ. 2023. PMID: 38052460 No abstract available.
Role of ZFHX4 in orofacial clefting based on human genetic data and zebrafish models.
Ishorst N, Hölzel S, Greve C, Yilmaz Ö, Lindenberg T, Lambertz J, Drichel D, Zametica B, Mingardo E, Kalanithy JC, Channab K, Kibris D, Henne S, Degenhardt F, Siewert A, Dixon M, Kruse T, Ongkosuwito E, Girisha KM, Pande S, Nowak S, Hagelueken G, Geyer M, Carels C, van Rooij IALM, Ludwig KU, Odermatt B, Mangold E. Ishorst N, et al. Among authors: dixon m. Eur J Hum Genet. 2024 Dec 19. doi: 10.1038/s41431-024-01775-9. Online ahead of print. Eur J Hum Genet. 2024. PMID: 39702590
Nivolumab plus Ipilimumab in Microsatellite-Instability-High Metastatic Colorectal Cancer.
Andre T, Elez E, Van Cutsem E, Jensen LH, Bennouna J, Mendez G, Schenker M, de la Fouchardiere C, Limon ML, Yoshino T, Li J, Lenz HJ, Manzano Mozo JL, Tortora G, Garcia-Carbonero R, Dahan L, Chalabi M, Joshi R, Goekkurt E, Braghiroli MI, Cil T, Cela E, Chen T, Lei M, Dixon M, Abdullaev S, Lonardi S; CheckMate 8HW Investigators. Andre T, et al. Among authors: dixon m. N Engl J Med. 2024 Nov 28;391(21):2014-2026. doi: 10.1056/NEJMoa2402141. N Engl J Med. 2024. PMID: 39602630 Clinical Trial.
Incidence of diabetes mellitus following hospitalisation for COVID-19 in the United Kingdom: A prospective observational study.
Tyrer F, Gharibzadeh S, Gillies C, Lawson C, Routen A, Islam N, Razieh C, Zaccardi F, Yates T, Davies MJ, Brightling CE, Chalmers JD, Docherty AB, Elneima O, Evans RA, Greening NJ, Harris VC, Harrison EM, Ho LP, Horsley A, Houchen-Wolloff L, Leavy OC, Lone NI, Marks M, McAuley HJC, Poinasamy K, Quint JK, Raman B, Richardson M, Saunders R, Sereno M, Shikotra A, Singapuri A, Wain LV, Khunti K; PHOSP‐COVID Study Collaborative Group. Tyrer F, et al. Diabetes Obes Metab. 2024 Nov 20. doi: 10.1111/dom.16071. Online ahead of print. Diabetes Obes Metab. 2024. PMID: 39563623
Glofitamab plus gemcitabine and oxaliplatin (GemOx) versus rituximab-GemOx for relapsed or refractory diffuse large B-cell lymphoma (STARGLO): a global phase 3, randomised, open-label trial.
Abramson JS, Ku M, Hertzberg M, Huang HQ, Fox CP, Zhang H, Yoon DH, Kim WS, Abdulhaq H, Townsend W, Herbaux C, Zaucha JM, Zhang QY, Chang H, Liu Y, Cheah CY, Ghesquieres H, Simko S, Orellana-Noia V, Ta R, Relf J, Dixon M, Kallemeijn M, Mulvihill E, Huang H, Lundberg L, Gregory GP. Abramson JS, et al. Among authors: dixon m. Lancet. 2024 Nov 16;404(10466):1940-1954. doi: 10.1016/S0140-6736(24)01774-4. Lancet. 2024. PMID: 39550172 Clinical Trial.
1,809 results